Trial Profile
A study to evaluate the effect of Midostaurin on ascites in patients with Aggressive Systemic Mastocytosis
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Midostaurin (Primary)
- Indications Systemic mastocytosis
- Focus Expanded access; Therapeutic Use
- 02 Sep 2016 New trial record